ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 722307 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 722307; 2) Community: the network communities that were significantly associated with the response to NSC 722307; 3) Molecule: the relationships between components within communities and NSC 722307; 4) MDR: the compounds that were significantly associated with the NSC 722307.

NSC Compound Enrichment Correlation
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.00701295499506023 0.3411151
NSC 734288 6-(3-Azidopropyl)-5,6-dihydro-7,8-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.00701295499506023 0.4109785
NSC 744688 Null 0.00701295499506023 0.33357709
NSC 755880 Mitomycin (USAN) 0.00701295499506023 0.4883559
NSC 764037 BP-1-102 0.00714731931708442 -0.011369081
NSC 254681 5(8H)-Naphthacenone, 8-acetyl-10-[(3-amino-2,3,6-trideoxy- .alpha.-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,~ 11-trihydroxy-12-imino-1-methoxy-, monohydrochloride, (8S-cis)- (9CI) 0.00714731931708452 0.41100621
NSC 58239 A 80021F34 0.00714731931708452 0.35393023
NSC 626715 10-EdAM 0.00714731931708452 0.41039331
NSC 107124 Camptothecin Derivative 0.00770426557728501 0.29715079
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.00770426557728501 0.54209499
Total:55  Current:12    [First] [Prev] [Next] [Last]